News

Blue shape

Latest press releases and news related to Tr1X

Press Release

September 13, 2024

Tr1X to Participate at Upcoming Healthcare Investment Conferences

View

View

Press Release

August 7, 2024

Tr1X Announces FDA Clearance of IND Application for TRX103, an Allogeneic Engineered Tr1 Treg Cell Therapy for Treatment-Refractory Crohn’s Disease.

View

View

Publications

July 17, 2024

Cellular immunotherapies and immune cell depleting therapies in inflammatory bowel diseases: the next magic bullet?

View

View

Press Release

July 10, 2024

Tr1X Announces First Patient Dosed in Proof of Concept GvHD Trial Evaluating TRX103, a First-in-Class Type 1 Treg (Tr1) Cell Therapy

View

View

Publications

April 19, 2024

Opportunities for Treg cell therapy for the treatment of human disease

View

View

Press Release

April 10, 2024

Tr1X Announces FDA Clearance of First Investigational New Drug Application for TRX103, an Allogeneic Regulatory T-Cell Therapy to Treat Autoimmune Diseases

View

View

Press Release

January 17, 2024

Tr1X, Inc. Announces $75 Million Series A Financing to Develop Best-in-Class Universal Allogeneic Regulatory T (Treg) and CAR-Treg Cell Therapies to Treat and Potentially Cure Autoimmune and Inflammatory Diseases

View

View

Interview

January 17, 2024

Graphite Bio co-founder debuts Treg cell therapy startup with $75M, aims to ‘trick’ immune system into resetting

View

View